A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain

Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activ...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of virology 2019-09, Vol.164 (9), p.2355-2358
Hauptverfasser: Nemoto, Manabu, Yamayoshi, Seiya, Bannai, Hiroshi, Tsujimura, Koji, Kokado, Hiroshi, Kawaoka, Yoshihiro, Yamanaka, Takashi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2358
container_issue 9
container_start_page 2355
container_title Archives of virology
container_volume 164
creator Nemoto, Manabu
Yamayoshi, Seiya
Bannai, Hiroshi
Tsujimura, Koji
Kokado, Hiroshi
Kawaoka, Yoshihiro
Yamanaka, Takashi
description Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid substitution reduces the cross-reactivity of antiserum against this former Japanese vaccine.
doi_str_mv 10.1007/s00705-019-04328-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2245646034</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2244442777</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-e38057e4a6b6b60c29e07863f39d5109bd38c529f139d6d313069a7db926e2873</originalsourceid><addsrcrecordid>eNp9kUtrFTEYhoMo9lj9Ay4k4KabaG4zSZalaBUKbnQdcjLfzEmZybS5FNqVP91MT1VwYQK5vN-TNyEvQm8Z_cAoVR9zG2hHKDOESsE1kc_QjrUV0cro52hHBZVE91SfoFc5X1PaBNG9RCeCca604Tv08xznEKcZsFtCXLHzYcD-4OIEOER8gMVN01xLiG2XYKgeMi4HwD6tOZMEzpdwF8o9XkfsYgkZUl2wm1yIuTQFw20NcTMb5wrxweE75_2m5JIa9Bq9GN2c4c3TfIp-fP70_eILufp2-fXi_Ip4KVkhIDTtFEjX71unnhugSvdiFGboGDX7QWjfcTOyJvSDYIL2xqlhb3gPXCtxis6Ovjdpva2Qi11C9jDPLsJas-Vcdr3sqZANff8Per3WFNvrNqo1rtRmyI_U408kGO1NCotL95ZRu-Vjj_nYlo99zMdu1u-erOt-geHPkd-BNEAcgdxKLYT09-7_2P4CRSCbkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2244442777</pqid></control><display><type>article</type><title>A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain</title><source>SpringerLink Journals - AutoHoldings</source><creator>Nemoto, Manabu ; Yamayoshi, Seiya ; Bannai, Hiroshi ; Tsujimura, Koji ; Kokado, Hiroshi ; Kawaoka, Yoshihiro ; Yamanaka, Takashi</creator><creatorcontrib>Nemoto, Manabu ; Yamayoshi, Seiya ; Bannai, Hiroshi ; Tsujimura, Koji ; Kokado, Hiroshi ; Kawaoka, Yoshihiro ; Yamanaka, Takashi</creatorcontrib><description>Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid substitution reduces the cross-reactivity of antiserum against this former Japanese vaccine.</description><identifier>ISSN: 0304-8608</identifier><identifier>EISSN: 1432-8798</identifier><identifier>DOI: 10.1007/s00705-019-04328-4</identifier><identifier>PMID: 31227892</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Amino acid substitution ; Antisera ; Biomedical and Life Sciences ; Biomedicine ; Brief Report ; Cross-reactivity ; Hemagglutinins ; Infectious Diseases ; Influenza ; Medical Microbiology ; Vaccination ; Vaccines ; Virology ; Viruses</subject><ispartof>Archives of virology, 2019-09, Vol.164 (9), p.2355-2358</ispartof><rights>Springer-Verlag GmbH Austria, part of Springer Nature 2019</rights><rights>Archives of Virology is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-e38057e4a6b6b60c29e07863f39d5109bd38c529f139d6d313069a7db926e2873</citedby><cites>FETCH-LOGICAL-c441t-e38057e4a6b6b60c29e07863f39d5109bd38c529f139d6d313069a7db926e2873</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00705-019-04328-4$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00705-019-04328-4$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31227892$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nemoto, Manabu</creatorcontrib><creatorcontrib>Yamayoshi, Seiya</creatorcontrib><creatorcontrib>Bannai, Hiroshi</creatorcontrib><creatorcontrib>Tsujimura, Koji</creatorcontrib><creatorcontrib>Kokado, Hiroshi</creatorcontrib><creatorcontrib>Kawaoka, Yoshihiro</creatorcontrib><creatorcontrib>Yamanaka, Takashi</creatorcontrib><title>A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain</title><title>Archives of virology</title><addtitle>Arch Virol</addtitle><addtitle>Arch Virol</addtitle><description>Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid substitution reduces the cross-reactivity of antiserum against this former Japanese vaccine.</description><subject>Amino acid substitution</subject><subject>Antisera</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Brief Report</subject><subject>Cross-reactivity</subject><subject>Hemagglutinins</subject><subject>Infectious Diseases</subject><subject>Influenza</subject><subject>Medical Microbiology</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Virology</subject><subject>Viruses</subject><issn>0304-8608</issn><issn>1432-8798</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNp9kUtrFTEYhoMo9lj9Ay4k4KabaG4zSZalaBUKbnQdcjLfzEmZybS5FNqVP91MT1VwYQK5vN-TNyEvQm8Z_cAoVR9zG2hHKDOESsE1kc_QjrUV0cro52hHBZVE91SfoFc5X1PaBNG9RCeCca604Tv08xznEKcZsFtCXLHzYcD-4OIEOER8gMVN01xLiG2XYKgeMi4HwD6tOZMEzpdwF8o9XkfsYgkZUl2wm1yIuTQFw20NcTMb5wrxweE75_2m5JIa9Bq9GN2c4c3TfIp-fP70_eILufp2-fXi_Ip4KVkhIDTtFEjX71unnhugSvdiFGboGDX7QWjfcTOyJvSDYIL2xqlhb3gPXCtxis6Ovjdpva2Qi11C9jDPLsJas-Vcdr3sqZANff8Per3WFNvrNqo1rtRmyI_U408kGO1NCotL95ZRu-Vjj_nYlo99zMdu1u-erOt-geHPkd-BNEAcgdxKLYT09-7_2P4CRSCbkA</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Nemoto, Manabu</creator><creator>Yamayoshi, Seiya</creator><creator>Bannai, Hiroshi</creator><creator>Tsujimura, Koji</creator><creator>Kokado, Hiroshi</creator><creator>Kawaoka, Yoshihiro</creator><creator>Yamanaka, Takashi</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20190901</creationdate><title>A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain</title><author>Nemoto, Manabu ; Yamayoshi, Seiya ; Bannai, Hiroshi ; Tsujimura, Koji ; Kokado, Hiroshi ; Kawaoka, Yoshihiro ; Yamanaka, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-e38057e4a6b6b60c29e07863f39d5109bd38c529f139d6d313069a7db926e2873</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Amino acid substitution</topic><topic>Antisera</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Brief Report</topic><topic>Cross-reactivity</topic><topic>Hemagglutinins</topic><topic>Infectious Diseases</topic><topic>Influenza</topic><topic>Medical Microbiology</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Virology</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nemoto, Manabu</creatorcontrib><creatorcontrib>Yamayoshi, Seiya</creatorcontrib><creatorcontrib>Bannai, Hiroshi</creatorcontrib><creatorcontrib>Tsujimura, Koji</creatorcontrib><creatorcontrib>Kokado, Hiroshi</creatorcontrib><creatorcontrib>Kawaoka, Yoshihiro</creatorcontrib><creatorcontrib>Yamanaka, Takashi</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Archives of virology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nemoto, Manabu</au><au>Yamayoshi, Seiya</au><au>Bannai, Hiroshi</au><au>Tsujimura, Koji</au><au>Kokado, Hiroshi</au><au>Kawaoka, Yoshihiro</au><au>Yamanaka, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain</atitle><jtitle>Archives of virology</jtitle><stitle>Arch Virol</stitle><addtitle>Arch Virol</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>164</volume><issue>9</issue><spage>2355</spage><epage>2358</epage><pages>2355-2358</pages><issn>0304-8608</issn><eissn>1432-8798</eissn><abstract>Equine influenza virus is an important pathogen for the horse industry because of its economic impact, and vaccination is a key control measure. Our previous work suggested that a mutation at position 144 in the hemagglutinin of Florida sublineage clade 2 viruses reduces the cross-neutralizing activity of antiserum against a former vaccine strain. To confirm this suggestion, here, we generated viruses by reverse genetics. Antibody titers against the mutated viruses were one-tenth to one-sixteenth of those against the former vaccine strain. Our findings confirm that this single amino acid substitution reduces the cross-reactivity of antiserum against this former Japanese vaccine.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>31227892</pmid><doi>10.1007/s00705-019-04328-4</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0304-8608
ispartof Archives of virology, 2019-09, Vol.164 (9), p.2355-2358
issn 0304-8608
1432-8798
language eng
recordid cdi_proquest_miscellaneous_2245646034
source SpringerLink Journals - AutoHoldings
subjects Amino acid substitution
Antisera
Biomedical and Life Sciences
Biomedicine
Brief Report
Cross-reactivity
Hemagglutinins
Infectious Diseases
Influenza
Medical Microbiology
Vaccination
Vaccines
Virology
Viruses
title A single amino acid change in hemagglutinin reduces the cross-reactivity of antiserum against an equine influenza vaccine strain
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T00%3A47%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20single%20amino%20acid%20change%20in%20hemagglutinin%20reduces%20the%20cross-reactivity%20of%20antiserum%20against%20an%20equine%20influenza%20vaccine%20strain&rft.jtitle=Archives%20of%20virology&rft.au=Nemoto,%20Manabu&rft.date=2019-09-01&rft.volume=164&rft.issue=9&rft.spage=2355&rft.epage=2358&rft.pages=2355-2358&rft.issn=0304-8608&rft.eissn=1432-8798&rft_id=info:doi/10.1007/s00705-019-04328-4&rft_dat=%3Cproquest_cross%3E2244442777%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2244442777&rft_id=info:pmid/31227892&rfr_iscdi=true